Thalassemic children have significant growth failure, lower total mean serum calcium, vitamin D, and PTH, high phosphorus levels, ALT and alkaline phosphatase, and dyslipidemia, as compared to controls, which signifies the importance of targeted therapeutic interventions to address this deficiency. The gene discussed is GPT; the disease is metabolic syndrome.